Molecular testing of rhabdomyosarcoma in clinical trials to improve risk stratification and outcome: A consensus view from European paediatric Soft tissue sarcoma Study Group, Children's Oncology Group and Cooperative Weichteilsarkom-Studiengruppe
Simone Hettmer(Martin Luther University Halle-Wittenberg), Janet Shipley(Institute of Cancer Research), Johannes H. M. Merks, Erin R. Rudzinski(Indiana University School of Medicine), Javed Khan(Kent State University), Samuel L. Volchenboum(University of Illinois Chicago), Olivia Ruhen(Institute of Cancer Research), Alexander R. Kovach(Duke University), Joanna Selfe(Institute of Cancer Research), Beat W. Schäfer(University Children's Hospital Zurich), Susanne A. Gatz(Institute of Cancer Research), Corinne M. Linardic(Duke University), Anna Kelsey, Rajkumar Venkatramani(Baylor College of Medicine), Véronique Minard‐Colin(Inserm), Monika Sparber‐Sauer(Olgahospital), Philip J. Lupo(Emory Healthcare), Gianni Bisogno(University of Padua), Ewa Kościelniak(University of Tübingen), Douglas S. Hawkins(Seattle Children's Hospital), Christian Vokuhl(University Hospital Schleswig-Holstein), Jack F. Shern(National Institutes of Health)
Cited by 73
Related Papers
Mutations of the BRAF gene in human cancer
|Nature|2002|10.7k
Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks
|Nature Medicine|2001|2.7k
Comprehensive Genomic Analysis of Rhabdomyosarcoma Reveals a Landscape of Alterations Affecting a Common Genetic Axis in Fusion-Positive and Fusion-Negative Tumors
|Cancer Discovery|2014|789
Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort
|European Journal of Cancer|2019|724